(Q44491532)

3 December 2017

title

Response to six classes of antihypertensive medications by body mass index in a randomized controlled trial (English)

1 reference

3 December 2017

Barry J Materson

1

1 reference

3 December 2017

David W Williams

2

1 reference

3 December 2017

Domenic J Reda

3

1 reference

3 December 2017

William C Cushman

4

1 reference

3 December 2017

Veterans Affairs Cooperative Study Group on Antihypertensive Agents

5

1 reference

3 December 2017

publication date

1 May 2003

1 reference

Journal of Clinical Hypertension

3 December 2017

published in

1 reference

3 December 2017

volume

5

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

197-201

1 reference

Secular blood pressure trends in normotensive persons: the Framingham Study

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Clinical management of the obese hypertensive patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Choice of drug treatment for obesity-related hypertension: where is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Therapeutic challenges in the obese diabetic patient with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Molecular biology of the calcium antagonist receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Impact of age, race, and obesity on hypertensive mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Cigarette smoking interferes with treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02029.X

10.1111/J.1524-6175.2003.02029.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference